AR038764A1 - Formulacion de una solucion de inhalacion con una sal de tiotropio - Google Patents

Formulacion de una solucion de inhalacion con una sal de tiotropio

Info

Publication number
AR038764A1
AR038764A1 ARP010105087A ARP010105087A AR038764A1 AR 038764 A1 AR038764 A1 AR 038764A1 AR P010105087 A ARP010105087 A AR P010105087A AR P010105087 A ARP010105087 A AR P010105087A AR 038764 A1 AR038764 A1 AR 038764A1
Authority
AR
Argentina
Prior art keywords
water
preservative
pharmacologically acceptable
preparation according
tiotropium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased/Invalidation/Refusal/Rejection/Nullification
Application number
ARP010105087A
Other languages
English (en)
Inventor
Petra Barth
Drechsel Karin Dr
Niklaus-Humke Barbara Dr
Schmelzer Christel Dr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of AR038764A1 publication Critical patent/AR038764A1/es
Ceased/Invalidation/Refusal/Rejection/Nullification legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Abstract

Una formulación para inhalación exenta de gases propelentes de bromuro de tiotropio o monohidrato de bromuro de tiotropio, disuelto en agua o en una mezcla de agua y etanol, así como a los aerosoles inhalables, exentos de gases propelentes, resultantes de ella. Reivindicación 1: Preparación medicamentosa compuesta por; una sal de tiotropio como principio activo, en una concentración referida a tiotropio, entre 0,0005 y 5% en peso; sólo agua o una mezcla de agua/etanol como disolvente para el principio activo; ácido para ajustar un valor de pH entre 2,0 y 4,5; un conservante farmacológicamente tolerable; opcionalmente, un formador de complejos y/o estabilizante farmacológicamente aceptable y/o un codisolvente farmacológicamente aceptable y/u otros coadyuvantes y aditivos farmacológicamente aceptables, además del conservante. Reivindicación 13: Preparación medicamentosa según una de las reivindicaciones 1 a 12, caracterizada porque la preparación contiene cloruro de benzalconio conservante. Reivindicación 14: Preparación medicamentosa según una de las reivindicaciones 1 a 13, caracterizada porque, además del conservante, se utilizan coadyuvantes y aditivos farmacológicamente aceptables. Reivindicación 28: Método para el tratamiento del asma y/o EPOC mediante el uso de una preparación medicamentosa según una de las reivindicaciones 1 a 17, en especial en un inhalador según una de las reivindicaciones 19 a 26. Reivindicación 29: Procedimiento para la elaboración de una preparación medicamentosa según una de las reivindicaciones 1 a 17, por medio de la mezcladura de los componentes individuales.
ARP010105087A 2000-10-31 2001-10-31 Formulacion de una solucion de inhalacion con una sal de tiotropio Ceased/Invalidation/Refusal/Rejection/Nullification AR038764A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10054036 2000-10-31

Publications (1)

Publication Number Publication Date
AR038764A1 true AR038764A1 (es) 2005-01-26

Family

ID=7661723

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010105087A Ceased/Invalidation/Refusal/Rejection/Nullification AR038764A1 (es) 2000-10-31 2001-10-31 Formulacion de una solucion de inhalacion con una sal de tiotropio

Country Status (39)

Country Link
EP (2) EP1333819B1 (es)
JP (1) JP4344135B2 (es)
KR (1) KR100853107B1 (es)
CN (2) CN100396285C (es)
AR (1) AR038764A1 (es)
AT (1) ATE373473T1 (es)
AU (2) AU2002221738B2 (es)
BG (1) BG66315B1 (es)
BR (1) BRPI0115076B8 (es)
CA (1) CA2426074C (es)
CY (1) CY1107825T1 (es)
CZ (1) CZ300794B6 (es)
DE (2) DE50113037D1 (es)
DK (1) DK1333819T3 (es)
EA (1) EA007604B1 (es)
EC (1) ECSP034541A (es)
EE (1) EE05314B1 (es)
ES (1) ES2294045T3 (es)
HK (1) HK1060524A1 (es)
HR (1) HRP20030338B1 (es)
HU (1) HU229411B1 (es)
IL (2) IL155538A0 (es)
ME (1) ME00244B (es)
MX (1) MXPA03003742A (es)
MY (1) MY138940A (es)
NO (1) NO332519B1 (es)
NZ (1) NZ526023A (es)
PE (1) PE20030092A1 (es)
PL (1) PL203316B1 (es)
PT (1) PT1333819E (es)
RS (1) RS50859B (es)
SA (1) SA01220482B1 (es)
SI (1) SI1333819T1 (es)
SK (1) SK286027B6 (es)
TW (1) TWI293885B (es)
UA (1) UA78690C2 (es)
UY (1) UY26989A1 (es)
WO (1) WO2002036104A2 (es)
ZA (1) ZA200302922B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
CN1292748C (zh) * 2003-03-05 2007-01-03 南昌弘益科技有限公司 噻托溴铵吸入粉雾剂及其制备工艺
PT1682541E (pt) * 2003-11-03 2010-04-14 Boehringer Ingelheim Int Processo para a preparação de sais de tiotrópio
PL2083007T3 (pl) * 2003-11-03 2013-09-30 Boehringer Ingelheim Int Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
EP1881980B1 (en) 2005-05-02 2012-08-22 Boehringer Ingelheim International GmbH Novel crystalline forms of tiotropium bromide
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
CN104306361A (zh) * 2014-09-24 2015-01-28 万特制药(海南)有限公司 一种含噻托溴铵的吸入性溶液
CN111374963A (zh) * 2018-12-31 2020-07-07 天津药业研究院有限公司 一种用于吸入的噻托铵溶液剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
KR20030060926A (ko) 2003-07-16
ZA200302922B (en) 2004-04-22
EE05314B1 (et) 2010-08-16
ME00244B (me) 2011-05-10
EP1333819A2 (de) 2003-08-13
HUP0301378A3 (en) 2005-12-28
UA78690C2 (uk) 2007-04-25
AU2173802A (en) 2002-05-15
HRP20030338B1 (en) 2011-09-30
HUP0301378A2 (hu) 2003-10-28
BRPI0115076B1 (pt) 2016-07-26
YU33003A (sh) 2006-05-25
HRP20030338A2 (en) 2005-04-30
DE10152521A1 (de) 2002-07-11
SA01220482B1 (ar) 2007-07-31
ES2294045T3 (es) 2008-04-01
SK286027B6 (sk) 2008-01-07
ECSP034541A (es) 2003-05-26
DE50113037D1 (de) 2007-10-31
WO2002036104A2 (de) 2002-05-10
SI1333819T1 (sl) 2007-12-31
WO2002036104A3 (de) 2002-08-01
BR0115076A (pt) 2003-07-29
PL203316B1 (pl) 2009-09-30
PE20030092A1 (es) 2003-03-24
KR100853107B1 (ko) 2008-08-21
UY26989A1 (es) 2002-06-20
NZ526023A (en) 2005-05-27
MEP40408A (en) 2011-02-10
EP1837021A3 (de) 2008-03-19
CN100396285C (zh) 2008-06-25
CA2426074C (en) 2008-12-23
IL155538A0 (en) 2003-11-23
HU229411B1 (en) 2013-12-30
RS50859B (sr) 2010-08-31
NO20031911L (no) 2003-04-29
CZ300794B6 (cs) 2009-08-12
MY138940A (en) 2009-08-28
CY1107825T1 (el) 2013-06-19
SK5272003A3 (en) 2003-10-07
TWI293885B (en) 2008-03-01
BG107727A (bg) 2004-11-30
ATE373473T1 (de) 2007-10-15
CZ20031486A3 (cs) 2003-08-13
HK1060524A1 (en) 2004-08-13
NO332519B1 (no) 2012-10-08
JP4344135B2 (ja) 2009-10-14
EA007604B1 (ru) 2006-12-29
EE200300203A (et) 2003-10-15
MXPA03003742A (es) 2004-10-15
CN101292964A (zh) 2008-10-29
EP1333819B1 (de) 2007-09-19
IL155538A (en) 2008-11-26
EP1837021A2 (de) 2007-09-26
JP2004512357A (ja) 2004-04-22
PT1333819E (pt) 2007-10-29
DK1333819T3 (da) 2007-12-03
BRPI0115076B8 (pt) 2021-05-25
AU2002221738B2 (en) 2007-01-11
BG66315B1 (bg) 2013-04-30
PL360405A1 (en) 2004-09-06
NO20031911D0 (no) 2003-04-29
CA2426074A1 (en) 2002-05-10
CN1473038A (zh) 2004-02-04
EA200300482A1 (ru) 2003-12-25

Similar Documents

Publication Publication Date Title
ES2566973T3 (es) Uso de SNS-595 para tratar leucemia
ES2391563T5 (es) Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor
ES2620413T3 (es) Formulaciones veterinarias antihelmínticas tópicas
AU775588B2 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
AR101593A2 (es) Formulación superfina de formoterol
AR038641A1 (es) Formulacion superfina de formoterol
ES2332290T3 (es) Formulaciones farmaceuticas que comprenden un agonista de beta2 de accion prolongada para su administracion mediante nebulizacion.
UA71585C2 (uk) Стійкий при зберіганні концентрат біологічно активної речовини формотеролу
ES2826562T3 (es) Solución para inhalación de tiotropio por nebulizador
PE20121396A1 (es) Composicion farmaceutica que comprende bromuro de glicopirronio y formoterol
CA2540174A1 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
ECSP045140A (es) Formulaciones farmacéuticas derivadas del platino
UA64736C2 (uk) Лікарський препарат у формі водного розчину
DE60114571D1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
CY1111159T1 (el) Πυκνα διαλυματα μεθοτρεξατης
EA003960B1 (ru) Устойчивый при хранении концентрат биологически активного вещества формотерола
RU2013104401A (ru) Фармацевтический препарат, содержащий ингибитор фосфодиэстеразы
JP2009521473A5 (es)
NZ604417A (en) Liquid nasal spray containing low-dose naltrexone
AR040450A1 (es) Formulacion superfina de salmeterol
JP2019531308A5 (es)
AR038764A1 (es) Formulacion de una solucion de inhalacion con una sal de tiotropio
CN104306361A (zh) 一种含噻托溴铵的吸入性溶液
AR085273A1 (es) Formulacion liquida libre de propelente que comprende una droga antimuscarinica
DK2934544T3 (en) PHARMACEUTICAL FORMULA INCLUDING CICLESONID

Legal Events

Date Code Title Description
FC Refusal